Century Therapeutics (IPSC) Earnings Date & Reports
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IPSC is expected to report earnings to fall 25.62% to -29 cents per share on March 12
Q4'25
Est.
$-0.30
Q3'25
Missed
by $0.01
Q2'25
Est.
$-0.38
Q1'25
Beat
by $0.96
Q4'24
Est.
$-0.41
The last earnings report on November 13 showed earnings per share of -40 cents, missing the estimate of -38 cents. With 678.15K shares outstanding, the current market capitalization sits at 47.35M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IPSC showed earnings on November 13, 2025. You can read more about the earnings report here.